Matches in Nanopublications for { ?s ?p "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP902523.RAmYwoO7OlQu8ZaVG7jx5MUE-puNKKSw0S1t2To25y_xU130_assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902523.RAmYwoO7OlQu8ZaVG7jx5MUE-puNKKSw0S1t2To25y_xU130_provenance.
- NP791508.RAjTT7s4B7f_Fv1PXEierr2o4C1uonH8-hUjrcALx1wSw130_assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791508.RAjTT7s4B7f_Fv1PXEierr2o4C1uonH8-hUjrcALx1wSw130_provenance.
- NP713109.RAAANu5Xx1JE2tW5l1OL9lCtTkP_LMMFg0uyHEZIVSV2Y130_assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713109.RAAANu5Xx1JE2tW5l1OL9lCtTkP_LMMFg0uyHEZIVSV2Y130_provenance.
- assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP606772.RAKphQNdx-hGvj99j7nD0QiPd86-G-dhTwtEK8IWsNCz8130_assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606772.RAKphQNdx-hGvj99j7nD0QiPd86-G-dhTwtEK8IWsNCz8130_provenance.
- assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP713110.RAhGejfWia5aP9auRfsbSg43lnjyu4Jmw5NwEumPLB1yQ130_assertion description "[Especially a defective insulin response in the liver contributes to the development of hyperglycemia, dyslipidemia and peripheral insulin resistance and may contribute to hepatic over-expression of PAI-1 in diabetes type 2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713110.RAhGejfWia5aP9auRfsbSg43lnjyu4Jmw5NwEumPLB1yQ130_provenance.